Raleigh Capital Management’s Arvinas ARVN Stock Holding History

Raleigh Capital Management’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-589	Closed	-$24.2K	–	982
2023 Q4	$24.2K	Buy	+589	New	+$13.8K	0.01%	404

Other funds holding ARVN

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Raleigh Capital Management's ARVN Position: Q1 2024 in Review

Raleigh Capital Management sold out of Arvinas (ARVN) in Q1 2024, closing a stake of 589 shares — an estimated $24.2K sold.

Raleigh Capital Management first reported a position in ARVN in Q4 2023 and held it in 1 quarter. The position peaked at $24.2K in Q4 2023. 223 funds tracked by Wall St. Rank hold ARVN as of Q1 2024.

Raleigh Capital Management reported no remaining Arvinas position as of Q1 2024 after selling out during the quarter.
Raleigh Capital Management sold 589 Arvinas shares in Q1 2024, an estimated $24.2K.
Raleigh Capital Management first reported a position in Arvinas in Q4 2023 and held it in 1 quarter.
Raleigh Capital Management's Arvinas position peaked at $24.2K in Q4 2023.
223 funds tracked by Wall St. Rank held Arvinas as of Q1 2024.

Based on Raleigh Capital Management's 13F filing for Q1 2024, filed 13 May 2024.